Literature DB >> 20178406

Insulin-like growth factor-I and growth differentiation factor-5 promote the formation of tissue-engineered human nasal septal cartilage.

Thomas H Alexander1, August B Sage, Albert C Chen, Barbara L Schumacher, Elliot Shelton, Koichi Masuda, Robert L Sah, Deborah Watson.   

Abstract

INTRODUCTION: Tissue engineering of human nasal septal chondrocytes offers the potential to create large quantities of autologous material for use in reconstructive surgery of the head and neck. Culture with recombinant human growth factors may improve the biochemical and biomechanical properties of engineered tissue. The objectives of this study were to (1) perform a high-throughput screen to assess multiple combinations of growth factors and (2) perform more detailed testing of candidates identified in part I.
METHODS: In part I, human nasal septal chondrocytes from three donors were expanded in monolayer with pooled human serum (HS). Cells were then embedded in alginate beads for 2 weeks of culture in medium supplemented with 2% or 10% HS and 1 of 90 different growth factor combinations. Combinations of insulin-like growth factor-I (IGF-1), bone morphogenetic protein (BMP)-2, BMP-7, BMP-13, growth differentiation factor-5 (GDF-5), transforming growth factor β (TGFβ)-2, insulin, and dexamethasone were evaluated. Glycosaminoglycan (GAG) accumulation was measured. A combination of IGF-1 and GDF-5 was selected for further testing based on the results of part I. Chondrocytes from four donors underwent expansion followed by three-dimensional alginate culture for 2 weeks in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5. Chondrocytes and their associated matrix were then recovered and cultured for 4 weeks in 12 mm transwells in medium supplemented with 2% or 10% HS with or without IGF-1 and GDF-5 (the same medium used for alginate culture). Biochemical and biomechanical properties of the neocartilage were measured.
RESULTS: In part I, GAG accumulation was highest for growth factor combinations including both IGF-1 and GDF-5. In part II, the addition of IGF-1 and GDF-5 to 2% HS resulted in a 12-fold increase in construct thickness compared with 2% HS alone (p < 0.0001). GAG and type II collagen accumulation was significantly higher with IGF-1 and GDF-5. Confined compression modulus was greatest with 2% HS, IGF-1, and GDF-5.
CONCLUSION: Supplementation of medium with IGF-1 and GDF-5 during creation of neocartilage constructs results in increased accumulation of GAG and type II collagen and improved biomechanical properties compared with constructs created without the growth factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20178406      PMCID: PMC2943402          DOI: 10.1089/ten.TEC.2009.0396

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  40 in total

1.  Human serum for tissue engineering of human nasal septal cartilage.

Authors:  Thomas H Alexander; August B Sage; Barbara L Schumacher; Robert L Sah; Deborah Watson
Journal:  Otolaryngol Head Neck Surg       Date:  2006-09       Impact factor: 3.497

2.  Osteogenic protein-1 promotes the formation of tissue-engineered cartilage using the alginate-recovered-chondrocyte method.

Authors:  K Masuda; B E Pfister; R L Sah; E J-M A Thonar
Journal:  Osteoarthritis Cartilage       Date:  2005-12-01       Impact factor: 6.576

3.  Basic fibroblast growth factor and insulinlike growth factor I support the growth of human septal chondrocytes in a serum-free environment.

Authors:  B P Dunham; R J Koch
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1998-12

4.  Effect of growth factors on cell proliferation, matrix deposition, and morphology of human nasal septal chondrocytes cultured in monolayer.

Authors:  Jeremy D Richmon; August B Sage; Elliot Shelton; Barbara L Schumacher; Robert L Sah; Deborah Watson
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

5.  Growth and phenotype of low-density nasal septal chondrocyte monolayers.

Authors:  David L Hicks; August B Sage; Barbara L Schumacher; Robert L Sah; Deborah Watson
Journal:  Otolaryngol Head Neck Surg       Date:  2005-09       Impact factor: 3.497

6.  Human serum for culture of articular chondrocytes.

Authors:  Tommi Tallheden; Josefine van der Lee; Camilla Brantsing; Jan-Eric Månsson; Eva Sjögren-Jansson; Anders Lindahl
Journal:  Cell Transplant       Date:  2005       Impact factor: 4.064

7.  In vitro redifferentiation of culture-expanded rabbit and human auricular chondrocytes for cartilage reconstruction.

Authors:  G J van Osch; S W van der Veen; H L Verwoerd-Verhoef
Journal:  Plast Reconstr Surg       Date:  2001-02       Impact factor: 4.730

8.  Depth- and strain-dependent mechanical and electromechanical properties of full-thickness bovine articular cartilage in confined compression.

Authors:  A C Chen; W C Bae; R M Schinagl; R L Sah
Journal:  J Biomech       Date:  2001-01       Impact factor: 2.712

9.  Cartilage-derived morphogenetic protein-1 promotes the differentiation of mesenchymal stem cells into chondrocytes.

Authors:  Xiaowen Bai; Zhifeng Xiao; Yuqiong Pan; Jiang Hu; Jens Pohl; Jinhua Wen; Lingsong Li
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

10.  Effect of growth factors on matrix synthesis by human nasal chondrocytes cultured in monolayer and in agar.

Authors:  J Bujía; P Pitzke; E Kastenbauer; E Wilmes; C Hammer
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

View more
  9 in total

1.  In vivo implantation of tissue-engineered human nasal septal neocartilage constructs: a pilot study.

Authors:  Angela A Chang; Marsha S Reuther; Kristen K Briggs; Barbara L Schumacher; Gregory M Williams; Maripat Corr; Robert L Sah; Deborah Watson
Journal:  Otolaryngol Head Neck Surg       Date:  2011-10-26       Impact factor: 3.497

2.  A compositional analysis of cadaveric human nasal septal cartilage.

Authors:  Monica K Neuman; Kristen K Briggs; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Laryngoscope       Date:  2013-07-02       Impact factor: 3.325

3.  Shape fidelity of native and engineered human nasal septal cartilage.

Authors:  Marsha S Reuther; Kristen K Briggs; Monica K Neuman; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Otolaryngol Head Neck Surg       Date:  2013-02-20       Impact factor: 3.497

4.  In vivo oxygen tension in human septal cartilage increases with age.

Authors:  Marsha S Reuther; Kristen K Briggs; Barbara L Schumacher; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  Laryngoscope       Date:  2012-06-27       Impact factor: 3.325

5.  Effect of hyaluronidase on tissue-engineered human septal cartilage.

Authors:  Deborah Watson; Marsha S Reuther; Van W Wong; Robert L Sah; Koichi Masuda; Kristen K Briggs
Journal:  Laryngoscope       Date:  2016-06-13       Impact factor: 3.325

6.  Volume Expansion of Tissue Engineered Human Nasal Septal Cartilage.

Authors:  Marsha S Reuther; Kristen K Briggs; Monica K Neuman; Koichi Masuda; Robert L Sah; Deborah Watson
Journal:  J Otol Rhinol       Date:  2014

7.  Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.

Authors:  Paul W Riem Vis; Joost P G Sluijter; R Sarita Soekhradj-Soechit; Lex A van Herwerden; Jolanda Kluin; Carlijn V C Bouten
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

8.  Optimization of the Expansion and Differentiation of Rabbit Chondrocytes In Vitro.

Authors:  T Mounts; N Ginley; M Schluchter; J E Dennis
Journal:  Cartilage       Date:  2012-04       Impact factor: 4.634

9.  Effect of oxygen tension on tissue-engineered human nasal septal chondrocytes.

Authors:  Chih-Wen Twu; Marsha S Reuther; Kristen K Briggs; Robert L Sah; Koichi Masuda; Deborah Watson
Journal:  Allergy Rhinol (Providence)       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.